ClinConnect ClinConnect Logo
Search / Trial NCT06901310

A Feasibility Study in Combat Athletes with Mild Traumatic Brain Injury

Launched by MICHAEL HARL · Mar 24, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

M Tbi, Brain Injury, Concussion

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Patients meeting the inclusion criteria will be based on the type of associated suspension; 30-day suspension (head injury without technical knockout or incapacitation), 60-day suspension (head injury with technical knockout or incapacitation), 90-day suspension (head injury with loss of consciousness). These suspension groups are not based on GCS; therefore, GCS is not part of the inclusion criteria. The suspension group injury severity would not include moderate to severe GCS \<13. This group will be divided into randomized groups, patients who will be treated with HBOT and patients who will receive the standard of care, which is rest.

About Michael Harl

Michael Harl is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a robust background in clinical development and regulatory compliance, Mr. Harl oversees a diverse portfolio of clinical trials across various therapeutic areas. His focus on innovation and collaboration fosters strong partnerships with research institutions and healthcare professionals, ensuring the highest standards of quality and integrity in trial execution. Through his leadership, Michael Harl aims to contribute to the development of safe and effective treatments that address unmet medical needs.

Locations

Marshfield, Wisconsin, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported